Yale Catriona Insider Trading Activity
Corporate InsiderChief Development Officer · CIK 1779308
Performance Scorecard
Forward stock performance after each transaction by Yale Catriona. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | +0.5% | 88% | 8 |
| 90 days | — | +14.6% | 71% | 7 |
| 120 days | — | +2.4% | 57% | 7 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersAKRO · Akero Therapeutics, Inc.
🔒 Subscribe to see trade entries
Pro members see exactly when Yale Catriona bought and sold AKRO.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Sep 11, 2025 | AKRO | Sell | 659 | $43.02 | $28K | −0.7% | Chief Development Officer | |
Jul 16, 2025 | AKRO | Sell | 1,342 | $53.47 | $72K | −1.4% | Chief Development Officer | |
Jul 16, 2025 | AKRO | Sell | 8,658 | $52.87 | $458K | −8.5% | Chief Development Officer | |
Jun 18, 2025 | AKRO | Sell | 1,633 | $54.84 | $90K | −1.8% | Chief Development Officer | |
Jun 16, 2025 Filed 4d late | AKRO | Sell | 2,895 | $54.80 | $159K | −3.0% | Chief Development Officer | |
Jun 16, 2025 Filed 4d late | AKRO | Sell | 6,210 | $53.78 | $334K | −6.1% | Chief Development Officer | |
Jun 16, 2025 Filed 4d late | AKRO | Sell | 895 | $55.52 | $50K | −1.0% | Chief Development Officer | |
Jun 10, 2025 | AKRO | Sell | 2,803 | $54.00 | $151K | −2.9% | Chief Development Officer |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| AKRO | Akero Therapeutics, Inc. | 8 | $1.3M |
Other insiders at Akero Therapeutics, Inc.
5 other tracked filers at AKRO.